Biofil Chemicals

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE829A01014
  • NSEID: BIOFILCHEM
  • BSEID: 524396
INR
32.49
-0.51 (-1.55%)
BSENSE

Aug 11

BSE+NSE Vol: 9.21 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 386748,
    "name": "Biofil Chemicals",
    "stock_name": "Biofil Chemicals",
    "full_name": "Biofil Chemicals & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/biofil-chemicals",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.49",
    "chg": -0.51,
    "chgp": "-1.55%",
    "dir": -1,
    "prev_price": "33.00",
    "mcapval": "55.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524396,
    "symbol": "BIOFILCHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE829A01014",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "9.21 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/biofil-chemicals-386748-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "386748",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/biofil-chemicals-pharmaceuticals-386748"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No. 02/2026-27) Of The Company Scheduled To Be Held On Tuesday 11Th August 2026.",
      "datetime": "01-Aug-2026",
      "details": "Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June 2026 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "01-Jul-2026",
      "details": "Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Jun-2026",
      "details": "Closure of Trading Window for the quarter ended 30.06.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(11 Aug 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No. 02/2026-27) Of The Company Scheduled To Be Held On Tuesday 11Th August 2026.

01-Aug-2026 | Source : BSE

Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June 2026 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

01-Jul-2026 | Source : BSE

Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended 30th June 2026.

Closure of Trading Window

25-Jun-2026 | Source : BSE

Closure of Trading Window for the quarter ended 30.06.2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(11 Aug 2026)

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available